Personalis (NasdaqGM:PSNL) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsAaron Tachibana - CFO and COOCaroline Corner - Investor Relations ContactChris Hall - CEO and PresidentJason Kritzer - Managing Director and Co-Head of Value TeamRich Chen - Chief Medical Officer and EVP of R&DTom Stevens - VPVidyun Bais - VP of Equity ResearchConference Call ParticipantsBill Bonello - Senior Research AnalystSubbu Nambi - Managing Director and Equity Research AnalystThomas Flaten - Senior Rese ...

Mesoblast (NasdaqGS:MESO) H1 2026 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsJames O'Brien - CFOMarcelo Santoro - Chief Commercial OfficerPaul Hughes - Head of Corporate Finance and Investor RelationsSilviu Itescu - CFO and Managing DirectorConference Call ParticipantsEdward Tenthoff - Managing Director and Senior Research AnalystMadeleine Williams - Equity Research AnalystMichael Okunewitch - Biotechnology Senior Research AnalystOlivia Brayer - Director and Senior Biotech AnalystOperat ...

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2025 on Thursday, March 12, 2026, After Close of U.S.-Based Financial Markets [Accessibility Statement] Skip NavigationSAN FRANCISCO, Feb. 26, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2025 on Thursday, March 12, 2026, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a con ...

should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in these forward-looking statements are reasonable based on information currently available to us, we cannot guarantee that the future results, discoveries, levels of activity, performance or events and circumstances reflected in forward-looking statements will be achieved or occur. Forward-looking statements involve known and unknown risks and uncertainties, some of which are ...

Emergent BioSolutions (NYSE:EBS) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Speaker2Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Frank Vargo, Treasurer. Please go ahead.Speaker0Good afternoon, everyone. Thank you for joining today as Emergent discusses their operational and financial results for the fourth quarter and full year of 2025. As is customary, today's call is open to all participants. The call is bei ...

Mesoblast (NasdaqGS:MESO) H1 2026 Earnings call February 26, 2026 05:00 PM ET Speaker6Hello, and welcome to the Mesoblast financial results for the half year ended December 31st, 2025. An announcement and presentation have been lodged with the ASX and are also available on the home and investor pages at www.mesoblast.com. At this time, all participants are in listen-only mode. Later, we will conduct a question and answer session and instructions will follow at that time. As a reminder, this conference call ...

OPKO Health (NasdaqGS:OPK) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsAdam Logal - SVP and CFOElias Zerhouni - Vice Chairman and PresidentGary Nabel - CIOPhillip Frost - Chairman and CEOYvonne Briggs - Director of Investor RelationsNone - Company RepresentativeConference Call ParticipantsBrian Cheng - Executive Director and Senior Biotech AnalystEdward Tenthoff - Managing Director and Senior Research AnalystMaury Raycroft - Equity Research AnalystYale Jen - Senior Biotech Analys ...

Puma Biotechnology (NasdaqGS:PBYI) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsAlan Auerbach - Executive Chairman, President, and CEOHeather Blaber - Senior Vice President of MarketingMariann Ohanesian - Senior Director of Investor RelationsMaximo Nougues - CFORoger Storms - Senior Vice President of SalesSalvatore Caruso - Biotech Equity Research AssociateOperatorGood morning. Oh, good afternoon, ladies and gentlemen. My name is Sherry, and I will be your conference call operator ...

Syndax Pharmaceuticals (NasdaqGS:SNDX) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsClara Dong - VP of Equity Research in BiotechnologyCorinne Johnson - Managing DirectorDavid Dai - DirectorJason Zemansky - VP of Equity ResearchJosh Bowen - DirectorKeith Goldan - CFOMichael Metzger - CEONick Botwood - Head of R&D and Chief Medical OfficerPriyanka Grover - VP of Biotechnology Equity ResearchSharon Klahre - Head of Investor RelationsStephen Willey - Managing DirectorSteve Closter - ...

Puma Biotechnology (NasdaqGS:PBYI) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsAlan Auerbach - Executive Chairman, President, and CEOHeather Blaber - Senior Vice President of MarketingMariann Ohanesian - Senior Director of Investor RelationsMaximo Nougues - CFORoger Storms - Senior Vice President of SalesSalvatore Caruso - Biotech Equity Research AssociateOperatorGood morning. Oh, good afternoon, ladies and gentlemen. My name is Sherry, and I will be your conference call operator ...